Markets

Novartis backs down

Novartis, the Swiss drug maker, has agreed to raise its takeover offer to minority shareholders in US specialist eyecare company Alcon. Lex's Edward Hadas and Luke Templeman discuss the rights and wrongs of offering minorities a discount price - and then backing down.